FMP
Meridian Bioscience, Inc.
VIVO
NASDAQ
Inactive Equity
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare brands; and urea breath testing for H. pylori under the BreathID and BreathTek brand. This segment also offers respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry products for LeadCare test kits for the detection of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
33.97 USD
0 (0%)
2022
2021
2020
2019
333.02M
317.9M
253.67M
201.01M
144.66M
116.75M
97.42M
82.69M
188.36M
201.15M
156.25M
118.33M
112.41M
107.63M
96.64M
80.98M
24.34M
23.91M
23.73M
17.95M
88.42M
79.12M
72.91M
63.03M
31.27M
26.78M
26.49M
28.45M
57.15M
52.34M
46.42M
34.59M
-350k
4.6M
0
0
55.51M
93.03M
61.32M
32.7M
-1.19M
-2.58M
-2.03M
-1.14M
54.32M
90.45M
59.29M
31.56M
11.86M
19.04M
13.11M
7.17M
42.46M
71.41M
46.19M
24.38M
0.96
1.62
1.07
0.57
0.96
1.62
1.07
0.57
44.01M
44.01M
43.17M
42.9M
44.01M
44.01M
43.17M
42.9M
72.02M
107.61M
75.49M
43.47M
2022
2021
2020
2019
180.7M
109.29M
63.11M
49.6M
42.46M
71.41M
46.19M
24.38M
0
0
0
0
0
0
0
-10.61M
223.16M
180.7M
109.29M
63.11M
42.46M
71.41M
46.19M
2.89M
2022
2021
2020
2019
50.71M
49M
37.46M
30.57M
16.51M
15.29M
13.57M
9.96M
-8.62M
-18.31M
-3.3M
-3.8M
42.81M
52.03M
27.19M
24.4M
2022
2021
2020
2019
1.63M
482k
24.95M
34.6M
114.67M
114.19M
89.24M
54.64M
116.3M
114.67M
114.19M
89.24M
All figures are in USD.